Cargando…

Parathyroid Carcinoma: An Up-to-Date Retrospective Multicentric Analysis

Parathyroid carcinoma (PC) is a rare disease responsible for about 1% of primary hyperparathyroidism (PHPT) cases. PC usually has an indolent course, tough to differentiate from the benign causes of PHPT, and the only certain diagnosis is histologic. The gold standard surgical treatment is the en bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Quaglino, Francesco, Manfrino, Luca, Cestino, Luca, Giusti, Massimo, Mazza, Enrico, Piovesan, Alessandro, Palestini, Nicola, Lauro, Corrado, Castellano, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079239/
https://www.ncbi.nlm.nih.gov/pubmed/32215010
http://dx.doi.org/10.1155/2020/7048185
_version_ 1783507787362336768
author Quaglino, Francesco
Manfrino, Luca
Cestino, Luca
Giusti, Massimo
Mazza, Enrico
Piovesan, Alessandro
Palestini, Nicola
Lauro, Corrado
Castellano, Elena
author_facet Quaglino, Francesco
Manfrino, Luca
Cestino, Luca
Giusti, Massimo
Mazza, Enrico
Piovesan, Alessandro
Palestini, Nicola
Lauro, Corrado
Castellano, Elena
author_sort Quaglino, Francesco
collection PubMed
description Parathyroid carcinoma (PC) is a rare disease responsible for about 1% of primary hyperparathyroidism (PHPT) cases. PC usually has an indolent course, tough to differentiate from the benign causes of PHPT, and the only certain diagnosis is histologic. The gold standard surgical treatment is the en bloc resection associated with the homolateral thyroid loboistmectomy. The aim of this study was to underline the main differences between PC and benign PHPT, along with gathering epidemiological knowledge relative to PC in our region. Data from the regional cancer network (Rete Oncologica del Piemonte e della Valle d'Aosta) since 2007 have been reported, including 21 patients from three hospitals (AO S. Croce e Carle of Cuneo, AOU Città della Salute of Turin, and ASL Città di Torino). The incidence of the disease, gender, age at time of diagnosis, presence of renal and bone symptoms, serum calcium and PTH levels, surgical technique performed, and percentage of recurrence were analysed. PC data were than compared with a series of patients affected by benign PHPT, referred to ASL Città di Torino, Maria Vittoria Hospital, from 2007 to 2019. A PC incidence of 0.05 cases per 100,000 inhabitants was found in our region. Benign forms occurred more frequently in females (p=0.0002), while PC equally occurred in males and females and affected younger patients (p=0.026). Serum calcium and PTH levels were significantly higher in PC patients; accordingly, typical PHPT symptoms were more frequently reported in PC than in benign PHPT. In the PC group, the en bloc resection shows a 13 times lower risk for relapse compared with all the other surgical techniques. PC is equally gender distributed, and the average patients' age is in the fifth decade of life. It is usually functioning, with greater biochemical activity and multiple symptoms. A not-radical surgical resection is associated with a higher recurrence rate. A meticulous presurgical evaluation of PHPT patients showing PC's evocative features is mandatory to obtain a complete disease extirpation.
format Online
Article
Text
id pubmed-7079239
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-70792392020-03-25 Parathyroid Carcinoma: An Up-to-Date Retrospective Multicentric Analysis Quaglino, Francesco Manfrino, Luca Cestino, Luca Giusti, Massimo Mazza, Enrico Piovesan, Alessandro Palestini, Nicola Lauro, Corrado Castellano, Elena Int J Endocrinol Research Article Parathyroid carcinoma (PC) is a rare disease responsible for about 1% of primary hyperparathyroidism (PHPT) cases. PC usually has an indolent course, tough to differentiate from the benign causes of PHPT, and the only certain diagnosis is histologic. The gold standard surgical treatment is the en bloc resection associated with the homolateral thyroid loboistmectomy. The aim of this study was to underline the main differences between PC and benign PHPT, along with gathering epidemiological knowledge relative to PC in our region. Data from the regional cancer network (Rete Oncologica del Piemonte e della Valle d'Aosta) since 2007 have been reported, including 21 patients from three hospitals (AO S. Croce e Carle of Cuneo, AOU Città della Salute of Turin, and ASL Città di Torino). The incidence of the disease, gender, age at time of diagnosis, presence of renal and bone symptoms, serum calcium and PTH levels, surgical technique performed, and percentage of recurrence were analysed. PC data were than compared with a series of patients affected by benign PHPT, referred to ASL Città di Torino, Maria Vittoria Hospital, from 2007 to 2019. A PC incidence of 0.05 cases per 100,000 inhabitants was found in our region. Benign forms occurred more frequently in females (p=0.0002), while PC equally occurred in males and females and affected younger patients (p=0.026). Serum calcium and PTH levels were significantly higher in PC patients; accordingly, typical PHPT symptoms were more frequently reported in PC than in benign PHPT. In the PC group, the en bloc resection shows a 13 times lower risk for relapse compared with all the other surgical techniques. PC is equally gender distributed, and the average patients' age is in the fifth decade of life. It is usually functioning, with greater biochemical activity and multiple symptoms. A not-radical surgical resection is associated with a higher recurrence rate. A meticulous presurgical evaluation of PHPT patients showing PC's evocative features is mandatory to obtain a complete disease extirpation. Hindawi 2020-03-06 /pmc/articles/PMC7079239/ /pubmed/32215010 http://dx.doi.org/10.1155/2020/7048185 Text en Copyright © 2020 Francesco Quaglino et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Quaglino, Francesco
Manfrino, Luca
Cestino, Luca
Giusti, Massimo
Mazza, Enrico
Piovesan, Alessandro
Palestini, Nicola
Lauro, Corrado
Castellano, Elena
Parathyroid Carcinoma: An Up-to-Date Retrospective Multicentric Analysis
title Parathyroid Carcinoma: An Up-to-Date Retrospective Multicentric Analysis
title_full Parathyroid Carcinoma: An Up-to-Date Retrospective Multicentric Analysis
title_fullStr Parathyroid Carcinoma: An Up-to-Date Retrospective Multicentric Analysis
title_full_unstemmed Parathyroid Carcinoma: An Up-to-Date Retrospective Multicentric Analysis
title_short Parathyroid Carcinoma: An Up-to-Date Retrospective Multicentric Analysis
title_sort parathyroid carcinoma: an up-to-date retrospective multicentric analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079239/
https://www.ncbi.nlm.nih.gov/pubmed/32215010
http://dx.doi.org/10.1155/2020/7048185
work_keys_str_mv AT quaglinofrancesco parathyroidcarcinomaanuptodateretrospectivemulticentricanalysis
AT manfrinoluca parathyroidcarcinomaanuptodateretrospectivemulticentricanalysis
AT cestinoluca parathyroidcarcinomaanuptodateretrospectivemulticentricanalysis
AT giustimassimo parathyroidcarcinomaanuptodateretrospectivemulticentricanalysis
AT mazzaenrico parathyroidcarcinomaanuptodateretrospectivemulticentricanalysis
AT piovesanalessandro parathyroidcarcinomaanuptodateretrospectivemulticentricanalysis
AT palestininicola parathyroidcarcinomaanuptodateretrospectivemulticentricanalysis
AT laurocorrado parathyroidcarcinomaanuptodateretrospectivemulticentricanalysis
AT castellanoelena parathyroidcarcinomaanuptodateretrospectivemulticentricanalysis